Crash, Budget Crunch Leave Science Anxious

With bears loose on the world’s major stock markets, academic, corporate and government scientists who seek cover face a forest of question marks. On Wall Street, where tremors from the recent precipitous plunge in share prices still ripple through the world economy, analysts predict an end to the easy credit and abundant capital that fueled recent growth in some science-based U.S. industries. While not everyone is predicting a recession, the prevailing mood is one of extremecaution,

Written byStephen Greene
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

With bears loose on the world’s major stock markets, academic, corporate and government scientists who seek cover face a forest of question marks.

On Wall Street, where tremors from the recent precipitous plunge in share prices still ripple through the world economy, analysts predict an end to the easy credit and abundant capital that fueled recent growth in some science-based U.S. industries. While not everyone is predicting a recession, the prevailing mood is one of extremecaution, if not outright gloom.

Several scientists said it was too early to predict the effect of the market crash on science budgets. Much depends, they said, on what steps Congress and the Reagan administration take to reduce the federal deficit. But they are alarmed by talk of a freeze on federal spending levels.

“I think it would be a horrendous tragedy to lop off funding in basic research at this time,” said Rita Colwell, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies